Safety review: Dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors William H. LudlamLowell Anthony Review Open access 28 September 2011 Pages: 825 - 841
Unapproved drugs in the united states and the food and drug administration Alexander NasrThomas J. LauterioMatthew W. Davis Review Open access 01 September 2011 Pages: 842 - 856
Pharmacokinetic pilot study of the antiangiogenic activity of standardized platycodi radix Emma M. TwinerZhijun LiuFrank Greenway Original Research 20 September 2011 Pages: 857 - 865
Efficacy of cilostazol for intracranial arterial stenosis evaluated by digital subtraction angiography/magnetic resonance angiography Keiichi YamadaYasuhiro Fujimoto Original Research 20 September 2011 Pages: 866 - 878
Long-term safety and efficacy of the recombinant human growth hormone omnitrope® in the treatment of Spanish growth hormone deficient children: Results of a phase III study J. López-SigueroV. Borrás PérezJ. Khan-Boluki Original Research 20 September 2011 Pages: 879 - 893
The “MESACA” study: Methylsulfonylmethane and boswellic acids in the treatment of gonarthrosis Angela NotarnicolaSilvio TafuriBiagio Moretti Original Research Open access 07 October 2011 Pages: 894 - 906
Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors Alpesh N. AminMehul JhaveriJay Lin Original Research 30 September 2011 Pages: 907 - 926